福井 敬祐　Keisuke Fukui

統計科学・がん疫学

• 日本統計学会
• 日本疫学会
• 公衆衛生学会

1. T. Tabuchi, K. Fukui, and S. Gallus, “Tobacco Price Increases and Population Interest in Smoking Cessation in Japan Between 2004 and 2016: A Google Trends Analysis,” Nicotine Tob. Res., no. May, pp. 1–6, 2018.
2. S. Kobayashi, K. Fukui, Y. Takeda, S. Nakahira, M. Tsujie, J. Shimizu, A. Miyamoto, H. Eguchi, H. Nagano, Y. Doki, and M. Mori, “Short-term outcomes of open liver resection and laparoscopic liver resection: Secondary analysis of data from a multicenter prospective study (CSGO-HBP-004),” Ann. Gastroenterol. Surg., vol. 2, no. 1, pp. 87–94, 2018.
3. K. Katayama, T. Kawaguchi, K. Shiraishi, T. Ito, and K. Suzuki, “The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease,” vol. 10, no. 5, pp. 437–444, 2018.
4. A. Yagi, Y. Ueda, M. Kakuda, Y. Tanaka, T. Egawa-Takata, A. Morimoto, T. Iwamiya, S. Matsuzaki, E. Kobayashi, K. Yoshino, K. Fukui, Y. Ito, T. Nakayama, and T. Kimura, “Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry,” Med. (United States), vol. 96, no. 32, 2017.
5.  S. Kobayashi, A. Tomokuni, K. Gotoh, H. Takahashi, H. Akita, S. Marubashi, T. Yamada, T. Teshima, K. Fukui, Y. Fujiwara, and M. Sakon, “A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer,” Eur. J. Surg. Oncol., vol. 43, no. 4, pp. 763–771, 2017.
6. T. Tabuchi, A. Goto, Y. Ito, K. Fukui, I. Miyashiro, and T. Shinozaki, “Smoking at the time of diagnosis and mortality in cancer patients: What benefit does the quitter gain?,” Int. J. Cancer, vol. 140, no. 8, pp. 1789–1795, 2017.
7. S. Shichijo, Y. Hirata, R. Niikura, Y. Hayakawa, A. Yamada, S. Mochizuki, K. Matsuo, Y. Isomura, M. Seto, N. Suzuki, H. Suzuki, S. Yamamoto, T. Sugimoto, T. Omae, M. Okamoto, H. Watabe, G. Togo, N. Takano, K. Fukui, Y. Ito, and K. Koike, “Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice,” J. Dig. Dis., vol. 17, no. 10, pp. 670–675, 2016.
8. K. Imanaka, K. Ohkawa, T. Tatsumi, K. Katayama, A. Inoue, Y. Imai, M. Oshita, S. Iio, E. Mita, H. Fukui, A. Yamada, F. Nakanishi, M. Inada, Y. Doi, K. Suzuki, A. Kaneko, S. Marubashi, Y. Ito, K. Fukui, R. Sakamori, T. Yakushijin, N. Hiramatsu, N. Hayashi, T. Takehara, and  the O. L. Forum, “Impact of branched-chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study,” Hepatol. Res., vol. 46, no. 10, pp. 1002–1010, 2016.
9. M. Yamamura, K. Fukui, and H. Yanagihara, “Illustration of the Varying Coefficient Model for a Tree Growth Analysis from the Age and Space Perspectives,” FORMATH, no. 0, pp. 1–9, 2016.
10. K. Fukui, “Consistency of log-likelihood-based information criteria for selecting variables in high-dimensional canonical correlation analysis under nonnormality,” Hiroshima Math. J., vol. 45, no. 2, pp. 175–205, 2015.
11. K. Fukui, M. Yamamura, and H. Yanagihara, “Comparison with Residual-Sum-of-Squares-Based Model Selection Criteria for Selecting Growth Functions,” FORMATH, vol. 14, pp. 27–39, 2015.
12. A. Kamada, H. Yanagihara, H. Wakaki, and K. Fukui, “Selecting a shrinkage parameter in structural equation modeling with a near singular covariance matrix by the GIC minimization method,” Hiroshima Math. J., vol. 44, pp. 315–326, 2014.
13. I. Nagai, K. Fukui, and H. Yanagihara, “Choosing the Number of Repetitions in the Multiple Plug-in Optimization Method for the Ridge Parameters in Multivariate Generalized Ridge Regression,” Bull. informatics Cybern., vol. 45, pp. 25–35, 2013.
14. K. Fukui and H. Yanagihara, “Selection of High-Dimensional Multivariate Linear Regression Models by Cross-Validation,” Proc. 6th Int. Conf. IMBIC Math. Sci. Adv. Sci. Technol. MSAST 2012 (eds. A. Adhikari M. R. Adhikari), pp. 108–117, 2012.